RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response
- 31 July 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (1) , 152-160
- https://doi.org/10.1016/j.ygyno.2004.03.035
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- P-glycoprotein: from genomics to mechanismOncogene, 2003
- The MRP family of drug efflux pumpsOncogene, 2003
- ABC-transporters: implications on drug resistance from microorganisms to human cancersInternational Journal of Antimicrobial Agents, 2003
- Overexpression of cMOAT (MRP2/ABCC2) Is Associated with Decreased Formation of Platinum-DNA Adducts and Decreased G2-Arrest in Melanoma Cells Resistant to CisplatinJournal of Investigative Dermatology, 2003
- Cellular roles of DNA topoisomerases: a molecular perspectiveNature Reviews Molecular Cell Biology, 2002
- Elevations of DNA Topoisomerase I in Invasive Carcinoma of the BreastThe Breast Journal, 2001
- Clinical applications of the camptothecinsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Competitive PCRNature, 1992
- Multidrug resistance (mdr) genes in human cancerBritish Journal of Cancer, 1991